← Leaderboards
Jonathan H Schatz
University Of Arizona
$2,947,463
Attributed
$4,368,852
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,368,852 · 3
By mechanism
R01$4,144,048 · 2
R41$224,804 · 1
Top collaborators
- Hassan Al-Ali2 shared
Most similar at University Of Arizona
Same institution · by research overlap
- Thomas P Miller$4,044,154
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsDesignInnovationDependenceTumorPhosphotransferasesKinase InhibitorMalignant NeoplasmsCellsBaseCell DeathPre-ClinicalPharmaceutical PreparationsPublishingEvaluationAffectIn VivoNew Therapeutic TargetToxic EffectDoseCancer ControlClinical AssessmentsDrug ExposureGrowth
Grant awards (7)
Essential role of the cyclin-G associated kinase (GAK) in diffuse large B-cell lymphoma progression$2,617,975
R01 · FY2025 · CA · contact PI
A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose$299,009
R01 · FY2018 · CA · contact PI
Developing a novel platform for rapid identification of drug targets and anti-targets$224,804
R41 · FY2018 · TR
A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose$299,009
R01 · FY2017 · CA · contact PI
A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose$299,009
R01 · FY2016 · CA · contact PI
A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose$312,436
R01 · FY2015 · CA · contact PI
A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose$316,610
R01 · FY2014 · CA · contact PI